EUCTR2018-003168-29-BE进行中（未招募）1 期
[18F]PSMA-11 PET/CT for prostate cancer – phase 3 clinical trial
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Patients diagnosed with prostate cancer, either in the setting of diagnosis of biochemical recurrence after previous treatment, or at primary diagnosis and staging
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 19
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 77
排除标准
- •- Age < 18 years
- •- Physically or mentally unfit to perform the sequential procedures
- •- Refusal of patient to be informed about accidental findings on scans
- •- History of anaphylactic shock after administration of Visipaque CT contrast
- •- Serum creatinine concentration > 2.0 mg/dl and/or estimated glomerular filtration rate < 60 ml/min
研究者
相似试验
进行中（未招募）
1 期
PSMA-PET/CT for prostate cancerEUCTR2017-003461-96-BEGhent University Hospital72
已完成
3 期
[18F]PSMA-11 PET/CT Phase 3 Clinical StudyProstate CancerNCT03911310University Hospital, Ghent96
进行中（未招募）
1 期
18F-PSMA PET in primary prostate cancer.75 patients with the suspicion on PCa (elevated PSA and/or abnormal digital rectal exam) will receive a PSMA-PET following mpMRI. 25 patients with PIRADS 1-2 (probably benign disease), 25 patients with PIRADS 3 (equivocal disease) and 25 patients with PIRADS 4-5 (highly suspicious for malignancy) will be included in this explorative study.MedDRA version: 20.0Level: LLTClassification code 10036921Term: Prostate carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-001387-28-NLRadboud University Medical Center75
已完成
2 期
18F-PSMA-1007 PET to detect primary prostate cancer: a comparative study with mpMRI and correlation to histopathologyProstate cancerNL-OMON49534Radboud Universitair Medisch Centrum75
招募中
3 期
18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028Prostate CancerNCT05520255University of Alberta2,800